Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Feb 7, 2008; 14(5): 725-730
Published online Feb 7, 2008. doi: 10.3748/wjg.14.725
Table 1 Patient characteristics
Patient, n = 80n/median (%/range)
Demographics
Age57 (17-79)
Sex, female26 (32.5)
Days of hospitalisation51 (3-241)
Required second hospitalisation5 (6.3)
Aetiology
Biliary26 (32.5)
Alcoholic32 (40.0)
Post-ERCP3 (3.8)
Toxic1 (1.3)
Hyperlipidemia1 (1.3)
Hyperparathyroidism1 (1.3)
Posttraumatic1 (1.3)
Idiopathic/unknown15 (18.8)
Ranson score2 (0-4)
Diagnostic procedures
Ultrasound74 (92.5)
ERCP32 (40.0)
CT80 (100)
Balthazar score4 (3-4)
CTSI6 (4-10)
Inflammatory markers
Leucocyte count d 1 of our hospital admission (/nL)13 (3.5-55.0)
Leucocyte count on day of first drainage placement (/nL)14.4 (3.5-46.6)
C-reactive protein day 1 (mg/L) of our hospital admission208 (10-477)
C-reactive protein on day of first drainage placement (mg/L)191 (20-477)
Therapy
Surgical20 (25.0)
Minimal-invasive
Number of drainages, range2 (1-14)
Active necrosectomy18 (22.5)
Intensive care treatment65 (81.3)
length of ICU stay, range22 (2-104)
Required second ICU stays9 (11.3)
APACHE II, range18 (1-38)
SAPS II, range61 (15-94)
Non-invasive positive pressure ventilation2 (2.5)
Mechanical ventilation50 (62.5)
Renal replacement therapy23 (28.8)
Plasma exchange therapy7 (8.8)
Mortality27 (33.8)
Cause of Death
Septic multi-organe failure24 (88.9)
Pulmonary embolism1 (3.7)
Intracerebral bleeding1 (3.7)
Due to polytrauma1 (3.7)
Table 2 Cox proportional hazard model for overall mortality using uni- and multivariate analysis
VariableMono-HRPMulti-HRP
Age0.9850.098-
Sex0.9260.793-
CTSI0.9330.2810.9820.819
Apache II Score0.9610.0160.9890.716
SAPS II Score0.9760.0021.0040.809
Clinical treatment modalities
Invasive ventilation0.1750.0005.6180.001
Renal replacement therapy0.3290.0052.3470.046
Interventional treatment modalities
Number of drainages0.8920.077-
Median drainage size0.9890.830-
Largest drainage size0.9540.307-
Total drainage plane0.9940.0520.9930.084
Table 3 Outcome parameters of patients after treatment with percutaneous drainage applied 1-12 years after hospital discharge by a telephone investigation
Outcome parameters from 29 patientsn%
Life quality parameters
Abdominal Pain517.2
Diarrhea724.1
Intolerance of fat413.8
Weight loss724.1
Exocrine pancreatic dysfunction (with substitution of pancreatic enzymes)724.1
Endocrine pancreatic dysfunction1034.5
Repeated development of pancreatitis310.3
Further hospitalisations827.6
Surgery after discharge724.1
Death after discharge413.8